Sun Pharma receives 483 for Baska facility, co says responded to USFDA

At the conclusion of the inspection, the US FDA issued a Form 483, with one observation for which the Company has submitted the response to the US FDA.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2CCuqCq
via IFTTT